- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
Phospho-APG4C-S451 Antibody Blocking PeptideSynthetic peptide
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| BP3364a | 0.1 mg 400 ul | In Stock | $ 45.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
Phospho-APG4C-S451 Antibody Blocking Peptide - Product info | |
| Primary Accession | Q96DT6 |
| Clone Names | 70226149 |
| Calculated MW | 52497 Da |
Phospho-APG4C-S451 Antibody Blocking Peptide - Additional info | |
| Gene ID 84938 | |
| Target/Specificity The synthetic peptide sequence used to generate the antibody AP3364a was selected from the region of human Phospho-APG4C-S451. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. | |
| Format Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. | |
| Precautions This product is for research use only. Not for use in diagnostic or therapeutic procedures. | |
Phospho-APG4C-S451 Antibody Blocking Peptide - Protein Information | |
| Name ATG4C | |
| Synonyms APG4C, AUTL1, AUTL3 | |
| Function Cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes | |
| Cellular Location Cytoplasm (Probable). | |
| Tissue Location Highly expressed in skeletal muscle, heart, liver and testis | |
Phospho-APG4C-S451 Antibody Blocking Peptide - Related products
AP1810a: ATG4C Antibody (N-term)
AP1810b: ATG4C Antibody (Center)
AP1810c: ATG4C Antibody (C-term)
AP3364a: Phospho-ATG4C-S451 Antibody
AP3392a: Phospho-ATG4C-S177 Antibody
AP3440a: Phospho-ATG4C-S398 Antibody
AP3456a: Phospho-ATG4C-S166 Antibody
RI10456: ATG4C predesign siRNA
LY10583a: ATG4C Over-expression Lysate
BP1810a: APG4C Antibody (N-term) Blocking Peptide
BP1810b: APG4C Antibody (Center) Blocking Peptide
BP1810c: APG4C Antibody (C-term) Blocking Peptide
BP1810d: APG4C Antibody (S398) Blocking Peptide
BP1810e: APG4C Antibody (S166) Blocking Peptide
BP3364a: Phospho-APG4C-S451 Antibody Blocking Peptide
BP3392a: Phospho-APG4C-S177 Antibody Blocking Peptide
Phospho-APG4C-S451 Antibody Blocking Peptide - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Autophagy is the process by which endogenous proteins and damaged organelles are destroyed intracellularly. Autophagy is postulated to be essential for cell homeostasis and cell remodeling during differentiation, metamorphosis, non-apoptotic cell death, and aging. Reduced levels of autophagy have been described in some malignant tumors, and a role for autophagy in controlling the unregulated cell growth linked to cancer has been proposed. This protein is a member of the autophagin protein family. This protein is also designated as a member of the C-54 family of cysteine proteases.APG4 is a cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes.
REFERENCES
Marino G., J. Biol. Chem. 278:3671-3678(2003).Ota T., Nat. Genet. 36:40-45(2004).The MGC Project Team, Genome Res. 14:2121-2127(2004).